311 related articles for article (PubMed ID: 6437432)
1. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
Wearne A; Joshua DE; Kronenberg H
Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulation and prognosis in myeloma.
Joshua DE; Wearne A; Kronenberg H
Lancet; 1987 Jan; 1(8527):251-3. PubMed ID: 2880070
[TBL] [Abstract][Full Text] [Related]
3. Monitoring circulating B cells in patients with multiple myeloma at diagnosis or in plateau phase: how prevalent is light chain isotype suppression?
King MA; Radicchi MA
Br J Haematol; 1992 Jun; 81(2):218-22. PubMed ID: 1379466
[TBL] [Abstract][Full Text] [Related]
4. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature.
Turesson I; Grubb A
Acta Med Scand; 1978; 204(6):445-51. PubMed ID: 104550
[TBL] [Abstract][Full Text] [Related]
5. Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: human B cells can simultaneously express cell surface kappa and lambda light chains.
Pauza ME; Rehmann JA; LeBien TW
J Exp Med; 1993 Jul; 178(1):139-49. PubMed ID: 8391059
[TBL] [Abstract][Full Text] [Related]
6. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
[TBL] [Abstract][Full Text] [Related]
7. Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group.
Leonard RC; MacLennan IC; Smart Y; Vanhegan RI; Cuzick J
Int J Cancer; 1979 Oct; 24(4):385-93. PubMed ID: 118938
[TBL] [Abstract][Full Text] [Related]
8. Monitoring myeloma: light chain isotype suppression. A new parameter.
Wearne A; Joshua DE; Kronenberg H
Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
[TBL] [Abstract][Full Text] [Related]
9. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
[TBL] [Abstract][Full Text] [Related]
10. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
Nelson M; Brown RD; Gibson J; Joshua DE
Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
[TBL] [Abstract][Full Text] [Related]
11. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.
Ioannidis RA; Joshua DE; Warburton PT; Francis SE; Brown RD; Gibson J; Kronenberg H
Hematol Pathol; 1989; 3(4):169-75. PubMed ID: 2516854
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
Yang JJ; Zhang GS; Chen XR
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
[TBL] [Abstract][Full Text] [Related]
14. Surface immunoglobulin light chain expression in pre-B cell leukemias.
Koziner B; Stavnezer J; Al-Katib A; Gebhard D; Mittelman A; Andreeff M; Clarkson BD
Ann N Y Acad Sci; 1986; 468():211-26. PubMed ID: 2425686
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the usefulness of measuring the serum and urine levels of light chain immunoglobulins in multiple myeloma and Waldenström's macroglobulinemia].
Kraj M; Maj S; Rostkowska J
Acta Haematol Pol; 1991; 22(1):21-30. PubMed ID: 1823963
[TBL] [Abstract][Full Text] [Related]
16. [Light chain myeloma or the pitfalls of myeloma diagnosis].
Zufferey P; Pugin P; Regamey C
Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
[TBL] [Abstract][Full Text] [Related]
17. Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphoma.
Sobol RE; Dillman RO; Collins H; Griffiths JC; Green MR; Royston I
Cancer; 1985 Oct; 56(8):2005-10. PubMed ID: 3928135
[TBL] [Abstract][Full Text] [Related]
18. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins.
Bagg A; Becker P; Bezwoda W; van Rensburg L; Mendelow B
Br J Haematol; 1989 Jun; 72(2):167-72. PubMed ID: 2503024
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
Solomon A; Weiss DT; Macy SD; Antonucci RA
Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
[TBL] [Abstract][Full Text] [Related]
20. [Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma].
Iavorskiĭ LI; Andreeva NE; Antipova LG; Riauzova LN
Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):3-9. PubMed ID: 111238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
